Erbitux ® (cetuximab) injection for intravenous infusion

100 mg in 50 mL vial; 200 mg in 100 mL vial

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

ERBITUX® (cetuximab): Storage and Stability

ERBITUX (cetuximab) should be stored in a manner consistent with its prescribing information.

Cetuximab is supplied as a sterile, preservative-free injectable liquid at concentrations of

  • 2 mg/mL as a 100 mg/50 mL, single-use vial (NDC 66733-948-23) or

  • 200 mg/100 mL, single-use vial (NDC 66733-958-23) (Erbitux Package Insert, 2016).

Storage

  • Do not freeze. Increased particulate formation may occur at temperatures at or below 32°F (0°C).

  • Store cetuximab vials under refrigeration at 36°F to 46°F (2°C to 8°C).

  • Preparations of cetuximab in infusion containers are chemically and physically stable at for up to

    • 12 hours at 36°F to 46°F (2°C to 8°C)

    • 8 hours at controlled room temperature 68°F to 77°F (20°C to 25°C) (Erbitux Package Insert, 2016).

Discard

  • Discard any remaining solution in the infusion container after 8 hours at controlled room temperature or after 12 hours at 36°F to 46°F (2°C to 8°C).

  • Discard any unused portion of the vial (Erbitux Package Insert, 2016).

Enclosed Prescribing Information

ERBITUX® (cetuximab) injection, for intravenous infusion, Lilly

Reference

Erbitux [package insert]. Indianapolis, IN: Eli Lilly and Company; 2016.



Date of Last Review: January 02, 2018

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical